Backing the science at inception
Pre-Seed to Series A, in the world’s deepest biotech ecosystem.
We invest in US companies whose edge is scientific: spinouts from leading labs and founders who can show a causally-validated target, a molecule designed to spec, or a delivery unlock. We underwrite that science earlier than most, and we stay close as it resolves.
Five things we need to see before the evidence makes it obvious.
The shift it rides
A clear answer to “why now”: causal target biology, design-to-spec, or a delivery unlock.
Research at the frontier
Teams whose work is published in leading peer-reviewed journals and who are recognized in their fields.
Protected IP
Differentiated intellectual property developed by, or with, the scientific founders.
A testable path to evidence
A credible go/no-go the next round can fund, not just a hypothesis.
A team that can build
Founders who can turn the science into a company.
Building a biotech company?
If your edge is the science, we’d like to see it early. Talk to our Venture team.